The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical and translational results from REVOLUTION cohorts A (nivolumab + ipilimumab + chemotherapy) and B (hydroxychloroquine + ipilimumab + chemotherapy) in patients with previously untreated metastatic pancreatic adenocarcinoma.
 
Eileen M. O'Reilly
Consulting or Advisory Role - Abbvie (I); AstraZeneca; Autem Medical (I); Berry Genomics (I); BioNTech SE; Boehringer Ingelheim; Bristol-Myers Squibb/Celgene; Eisai (I); Exelixis (I); Genentech/Roche (I); Ipsen; J-Pharma (I); Merck; Merus; Novartis; QED Therapeutics (I); SERVIER (I); Tempus; Vector Health (I); Yiviva (I)
Research Funding - Agenus (Inst); Arcus Ventures (Inst); AstraZeneca/MedImmune (Inst); BioNTech (Inst); Bristol Myers Squibb (Inst); Digestive Care (Inst); Elicio Therapeutics (Inst); Genentech (Inst); Helsinn Healthcare (Inst); Parker Institute for Cancer Immunotherapy (Inst); Puma Biotechnology (Inst); QED Therapeutics (Inst); Yiviva (Inst)
(OPTIONAL) Uncompensated Relationships - Thetis Pharma
 
Zev A. Wainberg
Consulting or Advisory Role - Alligator Bioscience; Amgen; Arcus Biosciences; Astellas Pharma; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; Daiichi Sankyo/Astra Zeneca; Ipsen; Lilly; Merck; Merck KGaA; Novartis; Pfizer; PureTech; Seagen
Research Funding - Five Prime Therapeutics (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Plexxikon (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Lilly; Merck
 
George A. Fisher
Honoraria - echina health
Consulting or Advisory Role - AstraZeneca; Genentech/Roche; Hutchison MediPharma
Research Funding - Genentech/Roche (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bristol Myers Squibb Foundation
 
Robert A. Wolff
Honoraria - Conveners; Emirates Oncology Society
Patents, Royalties, Other Intellectual Property - Royalties from McGraw-Hill: Editor: M.D. Anderson Manual of Medical Oncology, 3rd edition.
 
Andrew H. Ko
Honoraria - Medscape; MJH Life Sciences; Research to Practice
Consulting or Advisory Role - AADi; Arcus Biosciences; Eisai; FibroGen; Genentech; GRAIL; Merus; Roche/Genentech
Research Funding - AbGenomics International (Inst); Apexigen (Inst); Astellas Pharma (Inst); BioMed Valley Discoveries (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); CrystalGenomics (Inst); Genentech/Roche (Inst); Leap Therapeutics (Inst); Merck (Inst); Verastem (Inst)
 
Mark H. O'Hara
Consulting or Advisory Role - Alligator Bioscience; Geneos; Natera; Ono Pharmaceutical; PsiOxus Therapeutics; Strike Bio
Research Funding - Arcus Biosciences (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Genmab (Inst); HiberCell (Inst); Lilly (Inst); Natera (Inst); Parker Institute for Cancer Immunotherapy (Inst); PsiOxus Therapeutics (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune
 
Christine N Spencer
No Relationships to Disclose
 
Jia Xin Yu
Employment - Bristol-Myers Squibb
 
Diane M. Da Silva
Employment - Sanofi
 
Lacey J. Padron
No Relationships to Disclose
 
Jaclyn P. Lyman
No Relationships to Disclose
 
Jonni S. Moore
No Relationships to Disclose
 
Brandon Peng
No Relationships to Disclose
 
William Hoos
No Relationships to Disclose
 
Jill O'Donnell-Tormey
Leadership - Coherus Biosciences
Stock and Other Ownership Interests - Coherus Biosciences
Travel, Accommodations, Expenses - Coherus Biosciences
 
Silvia Boffo
Employment - Bristol-Myers Squibb
 
Ute Dugan
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Christopher R Cabanski
No Relationships to Disclose
 
Ravi K. Amaravadi
Stock and Other Ownership Interests - Pinpoint Therapeutics
Consulting or Advisory Role - Tasca Therapeutics
Research Funding - Bristol-Myers Squibb/Celgene (Inst); Deciphera (Inst); Merck KGaA (Inst); Pinpoint Therapeutics (Inst); SpringWorks Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - I am inventor on 3 patents related to dimeric chloroquines. The patents are owned by UPenn and licensed to Pinpoint Therapeutics (Inst)
Travel, Accommodations, Expenses - Merck KGaA
 
Robert H. Vonderheide
Consulting or Advisory Role - BMS GmbH & Co. KG
Patents, Royalties, Other Intellectual Property - Inventor on a licensed patient regarding cancer vaccine antigens; Receives royalties from Children’s Hospital Boston for a licensed research-only monoclonal antibody